当前位置: 首页 > 药学版 > 药品研究 > 药物与临床
编号:176403
阿尔马尔对35例偏头疼的预防作用
http://www.100md.com 2002年5月25日 新药网
     耿同超

    (中日友好医院,北京 100029)

    [摘要] 目的: 观察阿尔马尔对偏头痛的预防作用。方法:采用开放、自身对照试验。35例偏头痛患者服用阿尔马尔10mg,qd,症状改善不明显时,从第2或第3周开始,改为10mg, bid, 疗程4周。于治疗前和治疗后记录偏头痛发作次数、评价头痛程度。结果:患者服药4周后,偏头痛发作次数从5.2±3.0降至3.0±3.4(t=5.6,P<0.001),头痛程度自评分从8.1±0.7降至4.9±2.8(t=6.7,p<0.001〉。总有效率68.5%。结论:阿尔马尔可以降低偏头痛发作次数和头疼程度。

    [关键词] 偏头痛;α-受体阻滞剂;β-受体阻滞剂;阿尔马尔

    [中图分类号] R747.2;R969.4 [文献标识码] A [文章编号] 1003-3734(2001)

    Prophylaxis of Almarl for 35 cases of migraine

    GENG Tong-chao

    (Department of Neurology, China-Japan Friendship Hospital, Beijing 100029, China)

    [Abstract] Objective: To investigate the prophylaxis of almarl for migraine. Methods: 35 cases of migraine were treated in an open, self-controlled study with daily dose of Almarl 10 mg, qd. If no obvious improvement of migraine, 10 mg ,bid of almarl was given from second or third week. The attack and severity degree of migraine were recorded and evaluated pre-and post-treatment. Results: After the treatment of almarl for 4 weeks, the attack of migraine was reduced from 5.2±3.0 to 3.0±3.4(t = 5.6, p<0.001). The severity degree was reduced from 8.1±0.7 to 4.9±2.8 (t = 6.7, p<0.001). The total effective rate of almarl on migraine was 68.5%. Conclusion: Almarl can reduce both of the attack and severity of migraine.

    [Key words] migraine; α-receptor blocker; β-receptor blocker; almarl

    [作者简介]:耿同超(1956-),男,副主任医师,硕士。主要从事临床神经病学研究和工作。联系电话:64221122转3233。

    [参考文献]

    [1] 张健,谢晋湘,惠如太,等.阿罗洛尔降压疗效和对睡眠呼吸障碍的影响[J].中国循环杂志, 1998,13(6):331-333.

    [2] 柳泽信夫,田代邦雄,东议莫夫,ほか.Arotinololの本态性震颤に对する临床效果の检讨[J].临床医药,1993,9:1343-1371.

    [3] 寺本纯,永松正明,神原敏正.片头痛に对するArotinolol(ァルマ-ル?)の临床效果[J].新药と临床,1989,38(4):35-40.

    [4] 匡培根. 偏头痛发病机理及防治进展[J].世界医学杂志,2000,4(帕金森病及头痛临床与基础研究新进展研讨会):15-20.

    [5] 李舜伟.偏头痛的诊断和治疗[J].世界医学杂志,2000,4(帕金森病及头痛临床与基础研究新进展研讨会):21-23., http://www.100md.com